Olaplex Holdings, Inc. (OLPX) Market Cap
Olaplex Holdings, Inc. has a market capitalization of $1.36B.
Financials based on reported quarter end 2025-12-31
Price: $2.03
▼ -0.01 (-0.49%)
Market Cap: 1.36B
NASDAQ · time unavailable
CEO: Amanda G. Baldwin
Sector: Consumer Cyclical
Industry: Specialty Retail
IPO Date: 2021-09-30
Website: https://www.olaplex.com
Olaplex Holdings, Inc. (OLPX) - Company Information
Market Cap: 1.36B · Sector: Consumer Cyclical
Olaplex Holdings, Inc. manufactures and sells hair care products. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair. It provides hair care products to professional hair salons, retailers, and everyday consumers. The company was founded in 2014 and is based in Santa Barbara, California.
Analyst Sentiment
Based on 14 ratings
Analyst 1Y Forecast: $1.86
Average target (based on 5 sources)
Consensus Price Target
Low
$1
Median
$2
High
$3
Average
$2
Downside: -5.9%
Price & Moving Averages
Related Companies in Consumer Cyclical
SAVERS VALUE VILLAGE INC (SVV)
Consumer Cyclical
$1.35B
Mkt Cap
WENDYS (WEN)
Consumer Cyclical
$1.35B
Mkt Cap
G III APPAREL GROUP LTD (GIII)
Consumer Cyclical
$1.35B
Mkt Cap
TRIMAS CORP (TRS)
Consumer Cyclical
$1.41B
Mkt Cap
TRIPADVISOR INC (TRIP)
Consumer Cyclical
$1.31B
Mkt Cap
CARTERS INC (CRI)
Consumer Cyclical
$1.44B
Mkt Cap
Fundamentals Overview
Olaplex exited Q4 with improving momentum (positive sell-through exiting December) and delivered margin progress at the gross level (+200 bps in Q4 adj. GM; +40 bps for FY). However, management’s 2026 story contains clear near-term pressure points: Q1 revenue is expected below the full-year range and EBITDA “significantly below” range due to front-loaded marketing spend for No.3 and a less front-loaded 2025 “pipe” for launches. The company also flags operational complexity from the 2026 packaging rollout layered onto a multiyear innovation pipeline—an execution risk that could affect supply chain efficiency and conversion. In the Q&A, management pushed back on retailer concerns, attributing retail noise to international realignment rather than destocking failure, and emphasized sequential sell-through improvement and marketing leverage after Q1. Net: management is constructive on 2H inflection, but the analyst-facing details underscore a deliberate trade-off—spend now to generate later—creating earnings volatility in the first quarter.
Growth Catalysts
- Hero innovation: relaunch of No.1 Bond Multiplier and No.2 Bond Perfector (stand-alone, reduced purchase friction for pros)
- Major 2026 launch: No.3+ (three-minute in-shower treatment; positioned to drive premiumization)
- Market blitz/pro-first execution: 7 high-density markets; sell-through mid-teens higher in 60 days post-activation
- Improving sell-through momentum exiting December across key accounts
Business Development
- Pervala Bioscience acquisition (used to broaden innovation pipeline / potential additional health & beauty verticals)
- Professional education scaling: overhauled nearly 60 core educational assets (modular/digital-forward)
- Distribution/policy shift: international volume deliberately shifted from specialty retail partners toward pro partners
Financial Highlights
- FY2025 net sales: $423M (flat YoY); adjusted EBITDA margin: 22.2%
- Q4 2025 net sales: $105.1M (+4.3% YoY)
- Q4 adjusted gross profit margin: 70.6% (+200 bps YoY)
- FY2025 adjusted gross margin: 71.8% (+40 bps vs prior year)
- Q4 adjusted EBITDA: $12.9M (12.2% margin) vs 17.4% in Q4 2024
- FY2025 adjusted EBITDA: $93.9M (22.2% margin) vs 30.7% prior year (margin compression due to marketing/people investments)
- 2026 guidance (assumes no material tariffs): net sales -2% to +3% vs FY2025; adjusted gross margin 71%-72%; adjusted EBITDA margin 21%-22%
- Q1 2026 seasonality/cadence: management expects Q1 revenue below full-year guidance range and EBITDA significantly below the range due to front-loaded No.3 marketing spend and the more balanced (less front-loaded) innovation “pipe” vs prior year
Capital Funding
- Cash & cash equivalents at quarter end: $318.7M
- Debt at quarter end: $352.3M
- Operating cash flow: $58.7M for FY2025
- Inventory: $60.2M (down $15.0M vs $75.2M in 2024)
Strategy & Ops
- Brand/marketing engine: 360-degree marketing relaunch completed in 2025; continuing to optimize investment in 2026
- Packaging transition risk: 2026 rollout of new packaging (phased implementation) adds supply chain/operational complexity
- International realignment: shifted international volume toward professional channel; acknowledged as a contributor to retail noise
Market Outlook
- 2026 guidance: net sales approximately -2% to +3%; adjusted gross margin 71%-72%; adjusted EBITDA margin 21%-22%
- Demand weighted toward 2H: sell-through expected to sequentially improve and turn positive for the year
- Sell-through cadence: heroes and new launches build sequentially through the year; Q1 pressured then marketing efficiency improves YoY after Q1
Risks & Headwinds
- Operational hurdle: managing new packaging transition alongside a multiyear innovation pipeline (explicitly cited as adding operational complexity)
- Near-term earnings pressure: Q1 2026 EBITDA significantly below range due to marketing front-loading for No.3 launch and comparison headwind from a less concentrated 2025 innovation pipe
- Channel headwind: specialty retail declined sharply in Q4 (-14.5% YoY to $24.7M) attributed in part to international realignment “noise” impacting retail
- Sell-through remained down annually but improving sequentially; execution speed determines ability to hit the high end of 2026 ranges
- Tariffs/macro: management stated guidance assumes no material tariff impact and claimed global supply chain is minimally exposed; also noted potential geopolitical disruption is not included in guidance
Sentiment: MIXED
Note: This summary was synthesized by AI from the OLPX Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.